Kraig Biocraft Labs announced a plan to increase its recombinant spider silk output to 10 metric tons per month by May 2026, deploying its stockpile of proprietary silkworm eggs within the next 30 days and reaching full capacity in the first week of March.
The company’s CEO, Kim Thompson, said the 10‑ton target unlocks key markets for high‑performance apparel, technical textiles, and ballistic protection, calling the program “the most exciting and ambitious program for spider silk production the world has ever seen.”
Kraig has faced liquidity challenges, with a working‑capital deficit and a going‑concern warning reported in Q1 2025. The ramp‑up is intended to generate revenue streams that could reduce cash burn and move the company beyond pilot‑scale production.
The plan includes significant investments in facilities, workforce expansion, and a vertically integrated production infrastructure. Recent actions include acquiring mulberry fields for feedstock and completing a third rearing center in Southeast Asia to support the increased output.
While no market reaction data are available, the expansion positions Kraig to secure larger contracts and potentially attract non‑dilutive financing by demonstrating scalable manufacturing capability.
The milestone marks a critical step toward commercializing the company’s technology, but its success will depend on execution and market uptake of the new production capacity.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.